TriSalus Life Sciences, Inc. (TLSI)
3.57
-0.06
(-1.65%)
USD |
NASDAQ |
Oct 19, 15:29
TriSalus Life Sciences Price to Book Value : 33.50 for Oct. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 34.07 |
| October 15, 2026 | 36.60 |
| October 14, 2026 | 36.60 |
| October 13, 2026 | 37.54 |
| October 12, 2026 | 38.85 |
| October 09, 2026 | 38.10 |
| October 08, 2026 | 38.76 |
| October 07, 2026 | 39.88 |
| October 06, 2026 | 40.07 |
| October 05, 2026 | 41.10 |
| October 02, 2026 | 40.54 |
| October 01, 2026 | 38.95 |
| September 30, 2026 | 40.45 |
| September 29, 2026 | 39.88 |
| September 28, 2026 | 41.20 |
| September 25, 2026 | 40.73 |
| September 24, 2026 | 43.26 |
| September 23, 2026 | 46.92 |
| September 22, 2026 | 46.26 |
| September 21, 2026 | 46.73 |
| September 18, 2026 | 47.86 |
| September 17, 2026 | 45.98 |
| September 16, 2026 | 46.26 |
| September 15, 2026 | 44.86 |
| September 14, 2026 | 44.76 |
| Date | Value |
|---|---|
| September 11, 2026 | 43.78 |
| September 10, 2026 | 44.11 |
| September 09, 2026 | 44.67 |
| September 08, 2026 | 44.39 |
| September 04, 2026 | 46.92 |
| September 03, 2026 | 46.73 |
| September 02, 2026 | 48.24 |
| September 01, 2026 | 48.52 |
| August 31, 2026 | 46.45 |
| August 28, 2026 | 45.33 |
| August 27, 2026 | 46.26 |
| August 26, 2026 | 46.26 |
| August 25, 2026 | 47.20 |
| August 24, 2026 | 47.95 |
| August 21, 2026 | 49.46 |
| August 20, 2026 | 49.08 |
| August 19, 2026 | 51.52 |
| August 18, 2026 | 50.68 |
| August 17, 2026 | 49.46 |
| August 14, 2026 | 49.46 |
| August 13, 2026 | 52.83 |
| August 12, 2026 | 53.58 |
| August 11, 2026 | 53.87 |
| August 10, 2026 | 52.36 |
| August 07, 2026 | 52.65 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.597 |
| Alnylam Pharmaceuticals, Inc. | 23.12 |
| Anika Therapeutics, Inc. | 1.979 |
| Savara, Inc. | 6.663 |
| Vericel Corp. | 5.594 |
Price to Book Value Related Metrics
| PS Ratio | 3.970 |
| PEG Ratio | -0.2783 |
| Price | 3.57 |
| Earnings Yield | -36.27% |
| Market Cap | 219.45M |
| PEGY Ratio | -0.2783 |